Company intelligence / Profile preview

NGMedical

Nonnweiler, Saarland, Germanyngmedical.de ↗

Ownership: Private
Development stage: Commercial

Overview

NGMedical has launched several innovative spinal implant products in Europe and internationally. Its MOVE®-C cervical artificial disc prosthesis has over four years of clinical proof. The company’s BEE® line of interbody cages—including titanium additively manufactured devices and PEEK-based HA-enhanced cages—are CE-marked and commercially available in Europe; US FDA approval processes are ongoing with patient enrollment for pivotal trials nearing completion.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

3 assets

BEE interbody device

Commercial

Indications: Spinal disorders

2 more assets in the full pipeline.

Request access →

Partnerships

OrthoExOrtho Spine PartnersInvibio Biomaterial Solutions

Beyond the preview

Go deeper on NGMedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGMedical.

Explore the full profile